Another study that applied tissue microarrays to evaluate the immunohistochemical expression of CD59 in over 460 well characterized CRC cases similarly found an association between high CD59 expression and worse prognosis, a relationship that held particularly well for patients in the early stages of the disease [71]. Here, CD59 is linked to colorectal carcinoma.